TERT promoter mutations in familial and sporadic melanoma

Science

Volumn 339, Issue 6122, 2013, Pages 959-961

  Horn, Susanne ^a,b   Figl, Adina ^a,b   Rachakonda, P Sivaramakrishna ^a   Fischer, Christine ^c   Sucker, Antje ^b   Gast, Andreas ^a,b   Kadel, Stephanie ^a,b   Moll, Iris ^b   Nagore, Eduardo ^d   Hemminki, Kari ^a,e   Schadendorf, Dirk ^b   Kumar, Rajiv ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d INSTITUTO VALENCIANO DE ONCOLOGÍA   (Spain)

^e LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE REVERSE TRANSCRIPTASE; TERNARY COMPLEX FACTOR;

BIOASSAY; CANCER; CELL ORGANELLE; ENZYME ACTIVITY; GENE EXPRESSION; MUTATION; TUMOR;

ARTICLE; CANCER SUSCEPTIBILITY; GENE MUTATION; GENETIC ANALYSIS; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN CELL; LINKAGE ANALYSIS; MAJOR CLINICAL STUDY; MELANOMA; PRIORITY JOURNAL;

EID: 84874191269     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1230062     Document Type: Article

References (13)

1. Materials and methods are available as supplementary materials on Science Online.
2. Y. Akiyama, TFSearch, www.cbrc.jp/htbin/nph-tfsearch (1995).
3. P. Shore, A. D. Sharrocks, Nucleic Acids Res. 23, 4698 (1995).
4. D. Xu, J. Dwyer, H. Li, W. Duan, J.-P. Liu, J. Biol. Chem. 283, 23567 (2008).
5. M. Uhlen et al., Nat. Biotechnol. 28, 1248 (2010).
6. S. A. Forbes et al., Nucleic Acids Res. 39, D945 (2011).
7. V. N. Rao, E. S. Reddy, Oncogene 9, 1855
8. A. J. Whitmarsh, P. Shore, A. D. Sharrocks, R. J. Davis, Science 269, 403 (1995).
9. W. Lee, E. B. Keller, J. Mol. Biol. 220, 599 (1991).
10. G. C. Kujoth, D. F. Robinson, W. E. Fahl, Cell Growth Differ. 9, 523 (1998).
11. R. Janknecht, W. H. Ernst, A. Nordheim, Oncogene 10, 1209 (1995).
12. H. Davies et al., Nature 417, 949 (2002).
13. R. Kumar et al., Clin. Cancer Res. 9, 3362 (2003).